Immunohistochemical analysis of tumor samples before radiation showed positive EGFR staining in 9/10 cases (90%), positive ERCC1 staining in 5/10 cases (50%) and positive p53 staining in 5/10 cases (50%; Table 1). This evidence concerns the gene ERCC1 and neoplasm.